Menlo Park, CA, United States of America

Rick Bastin

This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Corcept Therapeutics Incorporated. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Rick Bastin. Retrieved from https://idiyas.com/inventor/rick-bastin

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Rick Bastin: Innovator in Glucocorticoid Receptor Modulation

Introduction

Rick Bastin is a notable inventor based in Menlo Park, California. He has made significant contributions to the field of pharmacology, particularly in the development of glucocorticoid receptor modulators. His work has the potential to impact various therapeutic areas.

Latest Patents

Rick Bastin holds a patent for formulations of dazucorilant, a glucocorticoid receptor modulator. The patent details formulations of (R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-4,4a,5,6,7,8-hexahydro-1H-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone, along with methods of making and using the same. This innovation represents a significant advancement in the field.

Career Highlights

Rick Bastin is currently employed at Corcept Therapeutics Incorporated, where he continues to work on innovative solutions in the pharmaceutical industry. His expertise and dedication have contributed to the company's mission of developing new treatments for patients.

Collaborations

Rick has collaborated with talented individuals such as Alla Hosny and Dolly Jacob. These partnerships have fostered a creative environment that encourages innovation and the development of new ideas.

Conclusion

Rick Bastin is a prominent inventor whose work in glucocorticoid receptor modulation is paving the way for new therapeutic options. His contributions to the field are invaluable, and his ongoing work at Corcept Therapeutics Incorporated continues to inspire advancements in medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…